In focus
Dr. Jaya Ranjalkar is the new Interim Director for ReAct Asia Pacific. She joined ReAct in 2017 as a Senior Research Officer. Dr. Ranjalkar is a medical doctor and has worked in various public health related projects before joining ReAct.
ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.
Community engagement
At the end of 2022, ReAct Latin America and partners produced a creative theatrical performance – Dancing with bacteria. The production used traditional music together with modern dance to raise awareness about antibiotic resistance.
Interview
Early 2022, Malin Grape was appointed by the Swedish Government as Sweden’s, and the world’s, first AMR Ambassador – to further strengthen global efforts against antimicrobial resistance. ReAct had the opportunity to talk to her about her role one year after her appointment and about antimicrobial resistance and the current Swedish EU Presidency.
News
End last year a new comprehensive study that analyses sewage samples from 234 cities in 101 countries was published. The study highlights the potential of a sewage-based global monitoring system. ReAct reached out to Professor Frank Aarestrup, co-conceiver and co-writer of the study, to learn more about the project and to hear his thoughts on monitoring and surveillance.
News
2022 is coming to an end. And the silent pandemic of antibiotic resistance is growing right before our eyes. 1,27 million people die from antibiotic resistance every year. 7,7 million people die from bacterial infections every year. To add on to this, bacteria see no borders – we all are connected – humans-animals-environment – so the challenge rises far beyond human health.
ReAct’s five nodes see these 15 things as key in 2023 – for a robust global response on antibiotic resistance:
Research and development
We are now well into a third decade of failure and standstill in developing new antibiotics. The traditional market-based financing model for research and development of new antibiotics continues to fail. There are five challenges governments need to address to resolve the stagnation in antibiotic development.
Interview
When Pernilla Rönnholm from Gothenburg, Sweden, gave birth to her twins Kirsty and Freya, only one of the girls survived. Kirsty died 8 days old from multi-drug resistant bacteria. Listen to the family’s story in an interview with the mother, Pernilla.
Theme
ReAct articles relating to COVID-19 and antibiotic resistance.
In the last 70 years the use of antibiotics has been crucial in improving countless lives and drastically reducing deaths caused by bacterial infections. The increasing development of antibiotic resistance is posing a serious threat to human health and development, the environment and for animal health. Learn more about antibiotic resistance here.
Donate
Your gift means a great deal. With your donation you will help address antibiotic resistance.
ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.
The ReAct Toolbox is a user-friendly web-based resource that provides inspiration and guidance to take action and develop national action plans on antibiotic resistance. It is built on what has been done in the past in a variety of settings, and is aligned with ongoing and current initiatives from across the globe.
Involved in developing and implementing your country's National Action Plan on AMR? Here you find support tools and inspiration.
Engagement from civil society organizations and communities is needed to tackle antibiotic resistance. Learn more about how to get involved.
Globally coordinated governance on antimicrobial resistance - to ensures a sustainable response that takes into account the conditions for LMICs
A public health driven and end-to-end approach to innovation that enables sustainable access to effective antibiotics in LMICs